|
GE Healthcare to Become Exclusive Distributor of Gamma Medica-Ideas Pre-Clinical Imaging Products |
|
Agreement strengthens both companies’ portfolios, gives customers greater access to pre-clinical imaging device
More... |
|
Gamma Medica-Ideas is developing a combined SPECT/MRI imaging system |
|
The picture at left shows GM-I’s SPECT/MRI prototype being inserted into a magnet - with GM-I’s recent introduction of a revolutionary fully solid-state SPECT gamma camera with no vacuum tubes, it is now possible to construct a combined SPECT/MRI system. MRI achieves highly detailed anatomical images without the use of imaging contrast agents, and can enhance tumor visibility when used with contrast agents. Together with SPECT, the most widely used nuclear medicine technique, a dual-modality SPECT/MRI imaging instrument will be able to acquire simultaneous high-resolution images registered in both time and location in a way that has never been done before. |
|
GM-I’s new VIVID™ software now available for FLEX Triumph™ |
|
GM-I’s new VIVID™ software package has been developed specifically for FLEX Triumph™ with a streamlined user interface. VIVID stands for Volumetric Image Visualization, Identification and Display and provides such advantages as automated fusion and display, automated loading of SPECT, PET and CT image data, and an automated visualization module for 2D, 3D, and single or multiple (fused) images. These and other features of GM-I’s new software package contribute to making the FLEX Triumph the most advanced pre-clinical imaging system in the world.
|
|
GM-I’s LumaGEM used for breast cancer detection at Mayo Clinic |
|
An ongoing study at the Mayo Clinic in Rochester, MN, using GM-I’s LumaGEM, found a sensitivity of over 90% for lesions less than 20 mm, 88% for lesions less than 10 mm and 75% for lesions less than 5 mm. This study demonstrated lesions as small as 3.3 mm. This patient population included women who were positive on mammogram. In a second study at Mayo in asymptomatic women with dense breasts and at high risk of breast cancer, preliminary results indicate that Molecular Breast Imaging may be able to detect significantly more tumors than screening mammography. |
|